The Future of Rapid Diagnostics: Why 15-Minute Two-Step PCR is Changing Healthcare

Two-step PCR, omitting the traditional 72°C extension phase and merging it with the 55°C annealing phase, combined with microfluidic rapid thermal cycling, is setting a new gold standard for point-of-care infectious disease testing.

This breakthrough technology means patients no longer wait days or hours for lab results. A Rapid Diagnostic Test (RDT) using two-step microfluidic PCR delivers highly sensitive quantitative data in just 15 minutes. From primary care clinics to global health initiatives, this speed is fundamentally changing the landscape of IVD.

TL
Global Agent · Duebio (TiosBio) · 20+ Years in IVD
IVD industry veteran specializing in CRISPR Cas12/Cas13 detection, RAA isothermal amplification, lateral flow assays, microfluidic PCR, TRF immunoassays, and OEM/ODM IVD development for global distributors. Duebio is the international trade brand of TiosBio, a Chinese IVD manufacturer with 20+ years of experience.

Leave a Comment